IDEXX Laboratories Inc at Raymond James Institutional Investors Conference (Virtual) Transcript
Sorry about that. Good morning, everyone. Welcome to the Raymond James Institutional Investor Conference. Thanks for joining us. I'm Andrew Cooper, and I cover animal health here for Raymond James. And we're excited to have IDEXX joining us this morning for a fireside chat.
Just some quick housekeeping. I'd love to include some questions from the audience today. (Operator Instructions)
Like I said, excited to have IDEXX, it's the largest player and, really, the leader in pretty much any sense of the word in animal diagnostics, which is one of the fastest-growing spaces in a really terrific end market.
With that, we have CEO, Jay Mazelsky here; as well as CFO, Brian McKeon. And Director of IR, John Ravis. And I'm going to jump right into some Q&A here.
Questions & Answers
Maybe just to start with some high
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |